Dr. Sreekanth C. Reddy
Claim this profileNorthside Hospital
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
7 reported clinical trials
15 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Sreekanth C. Reddy is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Sreekanth C. Reddy
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sreekanth C. Reddy has experience with
- Pembrolizumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Biospecimen Collection
- Crizotinib
- Talazoparib
Breakdown of trials Sreekanth C. Reddy has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sreekanth C. Reddy specialize in?
Sreekanth C. Reddy focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Sreekanth C. Reddy currently recruiting for clinical trials?
Yes, Sreekanth C. Reddy is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Sreekanth C. Reddy has studied deeply?
Yes, Sreekanth C. Reddy has studied treatments such as Pembrolizumab, Pemetrexed Disodium, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Sreekanth C. Reddy?
Apply for one of the trials that Sreekanth C. Reddy is conducting.
What is the office address of Sreekanth C. Reddy?
The office of Sreekanth C. Reddy is located at: Northside Hospital, Atlanta, Georgia 30342 United States. This is the address for their practice at the Northside Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.